795 APVO603: a dual 4-1BB and OX40 bispecific approach utilizing ADAPTIRTM technology designed to deliver a conditional T cell/NK response against solid tumors
oleh: Michelle Nelson, Jane Gross, Catherine McMahan, Ashly Lucas, Rebecca Gottschalk, Hilario Ramos
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.